Decision Layer
What to do with this topic
Use this page to decide whether hepatic lipid export belongs near the top of your follow-up list or stays in the background.
What to validate first
ALT / AST, triglycerides, liver-fat context
Why this topic matters
Hepatic lipid export becomes more useful when it is tied to real markers instead of isolated variants.
How to use this page
Use the decision layer first, then move into genes, biomarkers, and related symptom pages only if the topic still looks relevant.
Why It Rises Or Falls
How this topic earns attention
What this topic can explain
Add a liver-fat and triglyceride-export pathway that is distinct from general blood-lipid handling.
What usually moves it up the list
Hepatic lipid export rises when PNPLA3 and the supporting genes point in a coherent direction, and when the follow-up markers are practical enough to check early.
What usually keeps it in the background
A topic stays lower when the signal depends too heavily on symptoms alone or when other pathways show stronger, more testable drivers.
Validation markers commonly worth checking
ALT / AST
triglycerides
liver-fat context
Sample Report View
How Hepatic lipid export appears in the sample report
PNPLA3 is the main reason hepatic lipid export rises in the sample report. Additional context comes from TM6SF2, MBOAT7, HSD17B13.
Moderate follow-up priority
ALT / AST
This topic is worth validating if symptoms or existing labs point in the same direction, but it is not the first place to act.